The structural profiles are close, with DexCom carrying a narrow edge on profitability. Insulet still leads on growth and stability, which keeps the comparison from looking entirely one-sided. The market setup broadly confirms the structural lead — DexCom holds the more constructive position. That puts structure and market broadly in agreement — DexCom's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.
Profitability is the clearest driver, while growth keeps the result from looking one-way.
Both operate in: Medical Devices
This comparison is based on industry proximity, not on functional trajectory similarity. DXCM and PODD share the same industry classification.
For a similarity-based comparison, see how DexCom and Insulet each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in profitability.
Left means cheaper relative valuation. Higher means stronger structure.
The setup remains mixed because the stronger profile and the more supportive price setup do not sit on the same side.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where DXCM and PODD each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The profitability lead is mainly driven by a 8.3-point operating margin advantage.
Insulet still pushes back on growth, with a 20.8-point revenue-growth advantage that keeps the read from becoming one-way.
The main read on profitability is clearer than the broader score gap.
Break down the DXCM vs PODD comparison across all dimensions with the full interactive tool.
Explore how DXCM and PODD each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.